Coronavirus channel feed

FDA of­fi­cials, ex­perts dis­cuss im­pact of Covid-19 on cell and gene ther­a­pies

5 years ago
Cell/Gene Tx
FDA+

Covid-19 roundup: Can Ab­b­Vie’s dis­ap­point­ing NASH drug ceni­crivi­roc find suc­cess fight­ing cy­tokine storms?; Trump al­ly Chris Christie says he re­ceived Lil­ly's an­ti­body cock­tail

5 years ago

The prospect of an Oc­to­ber OK large­ly closed, Pfiz­er's Al­bert Bourla promis­es not to sub­mit for EUA un­til No­vem­ber

5 years ago
People
Pharma

WHO says remde­sivir has lit­tle ef­fect in hos­pi­tal­ized Covid-19 — but Gilead calls new da­ta 'in­con­sis­ten­t' with pre­vi­ous find­ings

5 years ago

Covid-19 roundup: Rus­sia ap­proves sec­ond vac­cine, Putin says; Ad­vo­ca­cy groups ask WTO to waive patent rights

5 years ago

The Sanofi/Trans­late team hits the green light on an ear­ly-stage study for their mR­NA Covid-19 vac­cine af­ter see­ing it work in an­i­mals

5 years ago
R&D

Covid-19 roundup: Mod­er­na starts lin­ing up po­ten­tial EU ap­proval for vac­cine; Hahn re­ject­ed White House push to re­brand EUA — Politi­co

5 years ago

Eli Lil­ly takes a one-two punch as Covid-19 an­ti­body com­bo study is halt­ed and man­u­fac­tur­ing ops fail in­spec­tion

5 years ago
Outsourcing

Covid-19 roundup: Vaxart dos­es first pa­tient in new clin­i­cal vac­cine study; NI­AID launch­es study to find po­ten­tial ther­a­pies in re­pur­posed drugs

5 years ago

An­oth­er safe­ty in­ci­dent trig­gers a halt to a piv­otal Covid-19 vac­cine study as J&J slams on the brakes

5 years ago

Covid-19 roundup: Pfiz­er strikes vac­cine deal with New Zealand, as CEO Al­bert Bourla de­fends de­vel­op­ment rush to crit­ics

5 years ago

As­traZeneca gets a $500M an­ti­body con­tract, yet key ques­tions still loom for Trump's new fa­vorite treat­ment

5 years ago

Covid-19 roundup: Chi­na joins vac­cine dis­tri­b­u­tion pro­gram re­ject­ed by Trump; Take­da and CSL-led al­liance be­gins blood plas­ma tri­al 

5 years ago

It's not just the an­ti­bod­ies: Eli Lil­ly bur­nish­es its sec­ond EUA in play with new Covid-19 da­ta on Olu­mi­ant plus remde­sivir

5 years ago
R&D

Covid-19 roundup: Azar says US could have vac­cines for all by March; Mod­er­na gets $56M to build mo­bile vac­cine 'fac­to­ry'

5 years ago

'I've au­tho­rized it' — Trump promis­es quick EUA and free ac­cess to Re­gen­eron's an­ti­body cock­tail, call­ing it a 'cure'

5 years ago

Af­ter two rounds of mixed da­ta, Eli Lil­ly im­press­es an­a­lysts with new Covid-19 an­ti­body re­sults. And ex­ecs want an EUA now

5 years ago
R&D

Covid-19 roundup: Ab­bott re­veals new test­ing kit da­ta; An OCD drug shows pos­i­tive signs in mild cas­es

5 years ago

BAR­DA chief turned whistle­blow­er Rick Bright re­signs from gov­ern­ment with one last broad­side against the Trump ad­min­is­tra­tion

5 years ago
People

Fac­ing broad push­back from in­dus­try, White House backs down on FDA's Covid-19 vac­cine guid­ance

5 years ago
FDA+

No new guid­ance, but here's some ad­vice: FDA draws a line in the sand for Covid-19 vac­cine de­vel­op­ers

5 years ago
FDA+

GSK, Vir cleared to leap in­to PhI­II, an­gling for a spot in the Covid-19 an­ti­body race led by Lil­ly, Re­gen­eron

5 years ago
R&D

Trump of­fi­cials said in­dus­try did­n't want FDA's stricter vac­cine guid­ance, but the lead­ing de­vel­op­er says they nev­er dis­cussed it

5 years ago
FDA+

Covid-19 roundup: Mod­er­na re­port­ed­ly lack­ing enough mi­nor­i­ty par­tic­i­pants; Pfiz­er, BioN­Tech and Re­gen­eron sued for al­leged patent in­fringe­ment

5 years ago
First page Previous page 41424344454647 Next page Last page
A service from the Financial Times